Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-26 @ 1:19 AM
Study NCT ID:
NCT03497533
Status:
UNKNOWN
Last Update Posted:
2019-09-06
First Post:
2018-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19
Sponsor:
Timmune Biotech Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-11
First Submit QC Date:
None
Study First Post Date:
2018-04-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-05
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL